Loading clinical trials...
Loading clinical trials...
For patients with chronic epiphora, Dacryocystorhinostomy is currently the gold standard treatment, with a success rate of 80-90% according to literature. Another available treatment, which is far les...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Shaare Zedek Medical Center
NCT06551766 · Chronic Dacryocystitis
NCT04968561 · Paranasal Sinus Diseases, Nasal Diseases, and more
NCT03436576 · Dry Eye, Keratoconjunctivitis Sicca, and more
NCT01826734 · Lacrimal Apparatus Diseases, Lacrimal Duct Obstruction
NCT00349297 · Dacryocystitis
Maccabi Healthcare Eye Clinic
Tel Aviv
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions